RE:Germany Legalization CaneIsAbel wrote: Will have the biggest impact for Tilray Brands of all companies that engage in cannabis sales. Tilray Pharma commands over 20 percent medical market share in the country with a DOMESTIC production GMP certified facility within the country. Some of the biggest MSO advocates admit this to be fact the dales report. Stands a reason Hudson Bay capital increased its postion to 38 million value more then all institutional investment in every MSO combined. Just about anyway
Medical cannabis in Europe is definately a great opportunity, but there are other factors that need to be considered alongside. First, medical sales represent 20% of the market, the other 80% is retail. So even if it were true that Tilray has 20% of the 20% of the total MJ market in Germany I have to question how many years will it take to get to the scale required for profitability? Tilray has not found the scale at home to be profitable, and now we will repeat the same formula in Germany, does that mean Tilray will move into the craft beer market in Germany to support the business until the required scale is reached? I still say show me the money before I invest anymore in this one, I see no near term improvement to get excited about yet.